NCT07245342Not yet recruiting
Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy
Early Electroacupuncture for Urinary Continence After Radical Prostatectomy: A Randomized, Single-Blind, Sham-Electroacupuncture-Controlled, Parallel-Group, Multicenter Clinical Trial
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
This clinical trial aims to find out if early electroacupuncture (EA) helps people recover the ability to control urination and is safe after surgery to remove the prostate gland for prostate cancer (radical prostatectomy). Participants are people aged 18 to 80 with localized prostate cancer who have had radical prostatectomy and are in good physical condition (ECOG score 0-1, meaning they can manage daily activities well). It will answer two key questions: Does early EA make more people fully control their urination 3 months after prostate surgery? How does early EA affect urination control and safety at 1, 6, and 12 months after surgery? Researchers will compare two groups: one getting EA and the other getting a fake version (sham EA ) to see if EA works better. Participants will start treatment 1 week after surgery, getting EA or sham EA 3 times a week for 6 weeks, 20 minutes each time. They will also complete tests to check urination control and fill out surveys about their urination, quality of life, and symptoms at different times. Their safety will be watched closely too.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 216 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- 25 Nov 2025
- Primary completion date
- 25 Nov 2028
- Lead sponsor
- Shanghai University of Traditional Chinese Medicine
- Diseases
- Prostate cancer
- NCT number
- NCT07245342
What you commit to
- Study type: Interventional
- Planned participants: 216
- From 25 Nov 2025 to the primary completion date, 25 Nov 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent urogenital infectious diseases (e.g., acute urethritis, acute cystitis).
- Previous prostate surgery.
- Receipt of any acupuncture treatment within one month prior to the study.
Other illness
- History of pelvic radiotherapy.
- Severe cardiovascular disease, hepatic or renal dysfunction, or coagulation disorders.
- Presence of psychiatric or psychological conditions impairing the ability to provide coherent feedback.
- Needle phobia, history of fainting during acupuncture, or strong aversion to acupuncture therapy.
- Any other condition considered by the investigators to render the patient unsuitable for study participation.
Other
- Presence of preoperative detrusor overactivity, urethral stricture, urge urinary incontinence, stress urinary incontinence, or overflow urinary incontinence.
- Preoperative International Prostate Symptom Score (IPSS) ≥ 20.
Who the study is looking for
- Patients aged 18 to 80 years (inclusive) with a diagnosis of localized prostate cancer scheduled for radical prostatectomy.
- Clinical tumor stage ≤ cT2bN0M0 confirmed by preoperative evaluation.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- Willingness to participate in the study and provision of written informed consent.
Age in the registry: 18 years to 80 years · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.